Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis코로나 바이러스 질병 2019를위한 항 바이러스 약물 (Covid-19) : 네트워크 메타 분석을 통한 체계적인 검토Meta-Analysis Published on 2022-02-012022-08-31 Journal: Expert review of anti-infective therapy [Category] COVID19(2023년), meta-analysis, SARS, 임상, 치료제, [키워드] all-cause mortality Antiviral antiviral drug antiviral drugs antivirals baloxavir baloxavir marboxil best Clinical practice comparison conducted controlled trials coronavirus disease COVID-19 diarrhea drug Efficacy Evidence hospitalized COVID-19 patients Interpretation Lopinavir nausea Network meta-analysis outcome outcomes patients Placebo Probability progression Randomized Randomized controlled trial Randomized controlled trials RCT RCTs Remdesivir retrieved Ritonavir Safety searched significantly increased Support systematic review Treatment triazavirin Viral viral clearance vomiting [DOI] 10.1080/14787210.2021.1961579 PMC 바로가기 [Article Type] Meta-Analysis
The efficacy of triazavirin (riamilovir)-based treatment for coronavirus disease 2019 (COVID-19) in clinical trials and preliminary practical experiencesReview Published on 2022-01-012023-07-11 Journal: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a [Category] COVID19(2023년), [키워드] clinical trials COVID-19 practical experiences Riamilovir SARS-CoV-2 triazavirin [Article Type] Review
Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Article Published on 2021-01-012023-06-23 Journal: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a [Category] SARS, 신종인플루엔자, [키워드] 3-chymotrypsin-like protease ACE-2 COVID-19 Drug repurposing SARS-CoV-2 structural proteins triazavirin